ClinVar Miner

Submissions for variant NM_000214.3(JAG1):c.2810G>A (p.Arg937Gln) (rs145895196)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000617476 SCV000736436 likely benign Cardiovascular phenotype 2017-07-20 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Subpopulation frequency in support of benign classification,in silico models in agreement (benign)
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000428738 SCV000510968 likely benign not provided 2017-02-13 criteria provided, single submitter clinical testing Converted during submission to Likely benign.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000195553 SCV000700821 likely benign not specified 2016-11-23 criteria provided, single submitter clinical testing
GeneDx RCV000195553 SCV000250453 likely benign not specified 2015-12-02 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Clinical Services Laboratory,Illumina RCV000278407 SCV000432893 likely benign Arteriohepatic dysplasia 2016-06-14 criteria provided, single submitter clinical testing
PreventionGenetics RCV000195553 SCV000303022 benign not specified criteria provided, single submitter clinical testing
SIB Swiss Institute of Bioinformatics RCV000755751 SCV000883285 benign Alagille syndrome 1 2018-10-15 criteria provided, single submitter curation This variant is interpreted as Benign, for Alagille syndrome 1, autosomal dominant. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. BS3 => Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.